Cargando…
Comparative Effectiveness of Di'ao Xin Xue Kang Capsule and Compound Danshen Tablet in Patients With Symptomatic Chronic Stable Angina
A high proportion of patients with stable angina remains symptomatic despite multiple treatment options. Di'ao Xinxuekang (XXK) capsule and Compound Danshen (CDS) tablet have been approved for treating angina pectoris for more than 20 years in China. We compare the anti-anginal effectiveness of...
Autores principales: | Yu, Yanan, Hu, Siyuan, Li, Guoxin, Xue, Jie, Li, Zhuoming, Liu, Xiangling, Yang, Xiyan, Dong, Bo, Wang, Donghai, Wang, Xiaofeng, Liu, Shurong, Liu, Jun, Chen, Bingwei, Wang, Liying, Liu, Songshan, Chen, Qiguang, Shen, Chunti, Wang, Zhong, Wang, Yongyan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4231340/ https://www.ncbi.nlm.nih.gov/pubmed/25394847 http://dx.doi.org/10.1038/srep07058 |
Ejemplares similares
-
Targeting Energy Protection as a Novel Strategy to Disclose Di’ao Xinxuekang against the Cardiotoxicity Caused by Doxorubicin
por: Wang, Tao, et al.
Publicado: (2023) -
Novel findings in relation to multiple anti-atherosclerotic effects of XueZhiKang in humans
por: Xu, Rui-Xia, et al.
Publicado: (2017) -
Di’ao Xinxuekang Capsule Improves the Anti-Atherosclerotic Effect of Atorvastatin by Downregulating the SREBP2/PCSK9 Signalling Pathway
por: Liang, Jiyi, et al.
Publicado: (2022) -
Xin-Ji-Er-Kang protects heart from ischemia-reperfusion injury by rebalancing lipid metabolism
por: Sun, Li-Jun, et al.
Publicado: (2022) -
Meta-Analysis of Randomized Controlled Trials on the Efficacy of Di'ao Xinxuekang Capsule and Isosorbide Dinitrate in Treating Angina Pectoris
por: Jia, Yongliang, et al.
Publicado: (2012)